Open AccessPharmaceutical Companies’ Role in State Vaccination Policymaking: The Case of Human Papillomavirus Vaccination
Author(s) -
Michelle M. Mello,
Sara Abiola,
James Colgrove
Publication year - 2012
Publication title -
american journal of public health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.284
H-Index - 264
eISSN - 1541-0048
pISSN - 0090-0036
DOI - 10.2105/ajph.2011.300576
Subject(s) - mandate , legislation , public relations , state (computer science) , business , vaccination , human papillomavirus , immunization , hpv vaccines , political science , public administration , medicine , cervical cancer , law , hpv infection , algorithm , cancer , antigen , computer science , immunology
We sought to investigate roles that Merck & Co Inc played in state human papillomavirus (HPV) immunization policymaking, to elicit key stakeholders' perceptions of the appropriateness of these activities, and to explore implications for relationships between health policymakers and industry.